Binding of β-Carbolines and Tetrahydroisoquinolines by Opiate Receptors of the δ-Type (original) (raw)
COMPARISON OF THE RECEPTOR BINDING CHARACTERISTICS OF OPIATE AGONISTS INTERACTING WITH μ- OR K-RECEPTORS
Kenneth Vaux
British Journal of Pharmacology, 1978
View PDFchevron_right
Binding and structure-activity-relation of benzo[f]isoquinoline- and norcodeinone-derivatives at μ-opioid receptors in the rat cerebral cortex
Michael Freissmuth
British Journal of Pharmacology, 1993
View PDFchevron_right
Study on the Activation of the Opioid Receptors by a Set of Morphine Derivatives in a Well-Defined Assay System
Olivier Civelli
Neurochemical Research, 2012
View PDFchevron_right
The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine
Fishman Jordan
Life Sciences, 1993
View PDFchevron_right
Opiate receptors: an introduction
John Carmody
Anaesthesia and intensive care, 1987
View PDFchevron_right
Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain
Stan Watson
Brain Research, 1986
View PDFchevron_right
(2S,3R)β-Methyl-2′,6′-dimethyltyrosine-l-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-l-Tic-OH] Is a Potent, Selective δ-Opioid Receptor Antagonist in Mouse Brain
Josue Lopez
Journal of Pharmacology and Experimental Therapeutics, 2003
View PDFchevron_right
(2S,3R)beta -Methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] Is a Potent, Selective delta -Opioid Receptor Antagonist in Mouse Brain
Victor Hruby
Journal of Pharmacology and Experimental Therapeutics, 2003
View PDFchevron_right
Opioid receptors in human neuroblastoma SH-SY5Y cells: Evidence for distinct morphine (μ) and enkephalin (δ) binding sites
Syed Mujab Kazmi
Biochemical and Biophysical Research Communications, 1986
View PDFchevron_right
Improved assays for the assessment of ϰ- and δ-properties of opioid ligands
susan j ward
European Journal of Pharmacology, 1982
View PDFchevron_right
Studies on spinal opiate receptor pharmacology. III. Analgetic effects of enkephalin dimers as measured by cutaneous-thermal and visceral-chemical evoked responses
David Rodbard
Brain Research, 1985
View PDFchevron_right
Relative efficacies of δ-opioid receptor agonists at the cloned human δ-opioid receptor
Victor Hruby is to
European Journal of Pharmacology, 1997
View PDFchevron_right
Pharmacological characterization of the binding of [ 3 H]bremazocine in guinea-pig brain: evidence for multiplicity of the κ-opioid receptors
Mario Tiberi
Canadian Journal of Physiology and Pharmacology, 1989
View PDFchevron_right
Irreversible labelling of rat brain opioid receptors by enkephalin chloromethyl ketones
Mária Wollemann, Mária Szücs
Neuropeptides, 1986
View PDFchevron_right
Subcellular Compartmentation of Opioid Receptors: Modulation by Enkephalin and Alkaloids
Rivka Levy
Journal of Neurochemistry, 1986
View PDFchevron_right
Leucine enkephalin noncompetitively inhibits the binding of [3H]naloxone to the opiate mu-recognition site: Evidence for delta←mu binding site interactions in vitro
Janine Danks
Neuropeptides, 1985
View PDFchevron_right
Reassessment of opioid binding sites in the rat brain
Noureddine Bourhim
Neuropeptides, 1986
View PDFchevron_right
Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists
Jonathan Katz
Life Sciences, 1983
View PDFchevron_right
The distribution of multiple opiate receptors in bovine brain
Mary Ninkovic
Brain Research, 1981
View PDFchevron_right
Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites
Kenner Rice
European Journal of Pharmacology, 1989
View PDFchevron_right
Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15)
Victor Hruby is to
Proceedings of the National Academy of Sciences, 1985
View PDFchevron_right
Novel Opiate Binding Sites Selective for Benzomorphan Drugs
Eli Hazum
Proceedings of The National Academy of Sciences, 1981
View PDFchevron_right
Evidence for μ opiate receptors on inhibitory terminals in area CA1 of rat hippocampus
Timothy Teyler
Neuroscience Letters, 1991
View PDFchevron_right
Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice
Lucyna Antkiewicz-michaluk, Irena Nalepa
Journal of Neural Transmission, 2001
View PDFchevron_right
Interactions of chloroquine with benzodiazepine, γ-aminobutyric acid and opiate receptors
Moshe Gavish
Biochemical Pharmacology, 1991
View PDFchevron_right
Receptors for morphine and opioids
Emilio Alejandro Hazas sanchez
General Pharmacology: The Vascular System, 1976
View PDFchevron_right
Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system
Michel Lazdunski
Brain Research, 1978
View PDFchevron_right
The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence
SUMANTRA DAS
Neuropeptides, 1984
View PDFchevron_right
Historical review: Opioid receptors
Mihaela Nemes
View PDFchevron_right
Psychotomimetic opiate receptors labeled and visualized with (+)-[3H] 3-(3-hydroxyphenyl)-N-(1-propyl) piperidine
Andrew Gundlach
Proceedings of the …, 1984
View PDFchevron_right
Different Regulation of Human δ-Opioid Receptors by SNC-80 [(+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and Endogenous Enkephalins
stephane allouche
Journal of Pharmacology and Experimental Therapeutics, 2004
View PDFchevron_right
Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity
Frank LaBella
Brain Research, 1979
View PDFchevron_right
Species differences in μ- and δ-opioid receptors
Jose Candido
European Journal of Pharmacology, 1991
View PDFchevron_right
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand
Edward Bilsky
European Journal of Pharmacology, 2014
View PDFchevron_right